These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2080345)

  • 1. Degenerative ultrastructural changes observed in the neuropil of caudate nuclei from Parkinson's disease patients.
    Machado-Salas J; Ibarra O; Martinez Fong D; Cornejo A; Aceves J; Kuri J
    Stereotact Funct Neurosurg; 1990; 54-55():297-305. PubMed ID: 2080345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.
    Hornykiewicz O
    Clin Neurol Neurosurg; 1992; 94 Suppl():S9-11. PubMed ID: 1320533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.
    Anglade P; Mouatt-Prigent A; Agid Y; Hirsch E
    Neurodegeneration; 1996 Jun; 5(2):121-8. PubMed ID: 8819132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
    Baloyannis SJ; Costa V; Baloyannis IS
    J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the existence of a projection from the dorsal column nuclei to the substantia nigra in the cat.
    Usunoff KG; Paloff AM
    J Hirnforsch; 1992; 33(4-5):445-9. PubMed ID: 1282531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a pallido-nigral projection innervating dopaminergic neurons.
    Hattori T; Fibiger HC; McGeer PL
    J Comp Neurol; 1975 Aug; 162(4):487-504. PubMed ID: 50334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
    Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
    Anglade P; Hirsch EC; Brandel JP; Javoy-Agid F; Duyckaerts C; Hauw JJ; Agid Y
    Ann Neurol; 1993 Jun; 33(6):662-3. PubMed ID: 8098934
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptic organization of cholinergic neurons in the monkey neostriatum.
    DiFiglia M
    J Comp Neurol; 1987 Jan; 255(2):245-58. PubMed ID: 3819015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis.
    Nemmi F; Sabatini U; Rascol O; Péran P
    Neurobiol Aging; 2015 Jan; 36(1):424-33. PubMed ID: 25174648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular degeneration in Parkinson's disease.
    Guan J; Pavlovic D; Dalkie N; Waldvogel HJ; O'Carroll SJ; Green CR; Nicholson LF
    Brain Pathol; 2013 Mar; 23(2):154-64. PubMed ID: 22897695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postnatal development of the monkey neostriatum: a Golgi and ultrastructural study.
    Difiglia M; Pasik P; Pasik T
    J Comp Neurol; 1980 Mar; 190(2):303-31. PubMed ID: 6769982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopsies during stereotaxic operations in Parkinson's syndrome].
    Riechert T; Gisinger MA; Mölbert E
    Neurochirurgia (Stuttg); 1967 May; 10(3):106-18. PubMed ID: 5340550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.